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NK  cells  are  defined  by  their  ability  to  lyse  target  cells  independent  of 
restriction by major histocompatibility antigens and without prior immunization 
(1).  Morphologically, NK cells appear to be a  homogeneous population of large 
granular lymphocytes (LGL) (2), but phenotypic characterization of cell surface 
antigens has revealed considerable heterogeneity and has not clearly defined the 
relationship of these cells to other lymphoid and hematopoietic populations. The 
most specific NK-associated  antigen appears  to be NKH1, a  200-kD  molecule, 
which is expressed on all NK cells in peripheral blood but only rarely expressed 
by other lymphoid or myeloid cells (3). Almost all NK cells express T1 1/E rosette 
receptor antigen (4);  however, despite this finding,  NK cells are considered to 
be a  unique population  that  is distinct from CTL  because the  majority of NK 
cells in peripheral blood do not express T  cell-like receptors for antigen (5). In 
contrast, studies with human NK clones (6, 7) have suggested that a subpopulation 
of T  cells  can  mediate  NK-like activity.  In  the  present  studies,  we  show  that 
normal peripheral  blood contains a  small  population  of cells that  express phe- 
notypic, morphologic, and functional characteristics of both human NK cells and 
T  cells. 
Materials and  Methods 
Monoclonal  Antibodies.  Anti-T3,  T4, T8,  and  T11  mAbs  have been previously de- 
scribed (8). Anti-NKH1A is an IgM mAb with the same specificity as anti-NKH1 (N901) 
(3). 
Analysis and Purification of Subpopulations  of PBMC.  Human PBMC were isolated from 
volunteer donors by Ficoll-Hypaque density gradient centrifugation. Two-color immu- 
nofluorescence analysis  was  accomplished by incubating cells  for 30  rain  at  4°C  with 
fluorescein-conjugated anti-NKH1a and a  phycoerythrin-conjugated mAb  (either anti- 
T3, T4, or T11 provided by Coulter Immunology, Hialeah, FL). In some experiments, 
anti-NKH1A-FITC was  used simultaneously with anti-T8 biotin (Coulter Immunology) 
followed by the addition of avidin conjugated phycoerythrin (AV-PE; Becton Dickinson 
& Co., Mountain View, CA). Background fluorescence was determined by incubating cells 
with a nonreactive fluorescein-conjugated antibody and either a nonreactive phycoery- 
thrin-conjugated antibody or a nonbiotinylated antibody followed by AV-PE. 
The simultaneous analysis  of green and red fluorescence was obtained from a single 
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TABLE  I 
Expression of T Cell Antigens on NKH  l a  + Cells in Normal Peripheral Blood 
Donor  N KH 1A  + 
T3 + NKH1A  +*  T4 + NKHIA +  T8 + NKH1A  +  TI 1  + NKHI^ + 
Total  NKHI ÷  Total  NKH1 ÷  Total  NKHI +  Total  NKH1 ÷ 
%  %  %  %  %  %  %  %  % 
1  19.4  1,9  9,8  0.4  2.3  --  --  11.3  53.0 
2  12.4  4.7  38.1  0.8  8.7  2.7  24.4  13.0  87.0 
3  8,3  2.7  31.8  0,2  2.9  --  --  9.5  100.0 
4  11.4  2.4  21.0  0.6  5.5  __  I  7.0  68.3 
5  7.7  1,2  15.2  1.0  14.8  2.1  25.4  10.0  67.2 
6  8.2  2.3  28.1  0.5  4.8  2.9  29.1  6.8  78.1 
Mean  11.2  2.5  24.0  0.6  6,5  2,6  26.3  9.6  75.6 
*  Number  of cells  expressing  both  cell  surface  antigens  was  determined  by  direct  immunofluorescence  and 
simultaneous  two-color analysis using an EPICS V.  10,000  cells were analyzed  in each experiment and results are 
expressed as percent  of total  PBMC and as a  percent of the number  of NKH1 + cells. 
laser exciting both FITC and PE at 488 nm using an Epics V (Coulter Electronics, Hialeah, 
FL). Electronic compensation for the small overlaps of green and red fluorescence yield 
signals essentially identical to those with either reagent alone.  10,000 cells were analyzed 
in  each sample and  results displayed as an  orthographic projection  plotting log green 
versus log red fluorescence. In the sorting experiments, NKH 1  +T3 + doubly fluorescent 
cells were separated from NKH 1  +T3- (green only) and from NKH l-T3 + (red only) cells. 
The purified cells were sorted in RPMI 1640 plus 10% pooled human AB serum at a rate 
of 3,000 cells/s. Cells were then washed twice and resuspended in RPMI 1640 containing 
5% AB serum for functional assays and cytocentrifuge smears. 
Cytotoxicity Assays.  Cytotoxicity assays were  performed  using a  standard  chromium 
release method previously described  (3).  In the  blocking studies  with anti-T3,  purified 
effector cells  were cultured overnight at 37°C after cell  sorting in the presence of anti- 
T3 or control antibody (anti-NKH 1A). Subsequently, mAbs were also added to individual 
wells for the 4 h cytotoxicity assay. 
Culture of Cell Sorter-pur~ed Subpopulations.  NKH 1A+T3  + cells purified by cell sorting 
were cultured  on a  feeder layer of irradiated  (5,000  rad) allogeneic PBMC plus EBV- 
transformed  B  cells  and  10%  lymphocyte-conditioned  medium.  After  10-14  d,  the 
polyclonal cell  lines contained 60-80% T3+NKH I + cells.  These cells were then resorted 
as described above, to obtain a  population  that was >95%  T3+NKH1 +.  Resorted cells 
were then used for cytotoxicity assays without further in vitro culture. 
Results 
Two-Color Analysis of Peripheral Blood Lymphocytes.  In  order  to evaluate  the 
coexpression of NKH 1 and T  cell antigens, PBMC from six different individuals 
were examined (Table  I). The mean percent  of NKH l+T3 + cells in peripheral 
blood  was  2.5%  of PBMC.  This  represents  ~24%  of the  NKH1 ÷  population. 
The T4 antigen is very rarely coexpressed with NKH 1 and <1% of total PBMC 
express  this  phenotype.  NKHI+T8 + cells compose ~2.6%  of total  PBMC  and 
this represents 26.3%  of all NKH1 + lymphocytes, a  number quite similar to the 
percentage of NKHI+T3 + cells.  It is thus likely that many NKHI+T3 + lympho- 
cytes also coexpress T8 antigen.  In this regard, it should be noted that almost all 
NK-active clones  that  express both  NKH1  and  T3  also coexpress T8  antigen. 
NKHI+Tt  1  + lymphocytes make up 9.6%  of total PBMC.  Unlike other T  cell- 
associated antigens, T 11 + cells represent the great majority of the NKH 1 + subset. 
Purification ofNKHI+T3 + Cells.  After showing  the presence of NKHI+T3 + 
lymphocytes  in  peripheral  blood,  we  used  immunofluorescent  cell  sorting  to SCHMIDT  ET  AL.  BRIEF  DEFINITIVE REPORT  353 
FIGURE  1.  Two-color immunofluorescence cell sorter purification  of peripheral  blood lym- 
phocyte subpopulations.  (A) Pre-sort analysis with  anti-NKHIa-FITC (y-axis) and anti-T3- 
phycoerythyrin (x-axis); (B) post-sort analysis of purified NKH 1  ÷T3 + cells; (C) post-sort analysis 
of purified NKH 1-T3  ÷ cells; (D) post-sort analysis of purified NKH 1  +T3- cells. 
FIGURE 2.  Morphology of NKH l+T3  - (A), NKHI+T3  ÷ (B), and NKH1-T3  + (C) lymphocyte 
populations.  Cytocentrifuge smears  of cell sorter-purified  populations  were  stained  with 
Wrights Giemsa. 
purify these  cells  for further  characterization.  Fig.  1 A  shows the  presence  of a 
small  population  of  NHKI+T3  +  cells  in  a  representative  sample  before  cell 
sorting.  Fig.  1 B  shows the post-sort analysis of the purified  NKH 1  +T3 ÷ cells.  In 
this  experiment,  84%  of sorted  cells  coexpress  T3  and  NKH1.  The  post-sort 
analysis  of NKH1-T3  + and  NKHl+T3--purified  cells  is  shown  in  C  and  D.  As 
shown in  Fig.  2,  both  NKHI+T3  -  cells (Fig.  2A) and  NKHI+T3  + cells (B) have 354  SCHMIDT  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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F[GUP.E  3.  NK activity of NKHI+T3 ÷ lymphocytes and inhibition by anti-T3 antibody.  (A) 
Cytolytic activity of purified subpopulations obtained from peripheral blood. Specific cytotox- 
icity  was  measured  at  various  E/T  cell  ratios  for  NKHI+T3 ÷  (--),  NKHI+T3 -  (---),  and 
NKH1-T3 ÷ (....)  cells. (O) cytotoxic activity in  the presence of media only.  (0) cytotoxicity 
after addition of anti-T3 antibody. (B) Cytolytic activity of cultured NKH I+T3 ÷ lymphocytes. 
Cytotoxicity assays were performed in the presence of media (--), anti-NKH1A (....), or anti- 
T3  (---)  mAb. Results were  obtained  from two different experiments: sort A  (©) and sort  B 
(0). K562 target cells were used in all experiments. 
the typical structural appearance  of LGL, whereas  NKH1-T3 + cells  (C)  show 
the characteristics of small T  lymphocytes. 
NK Activity ofNKHI+T3 + Lymphocytes.  When tested against K562 target cells, 
purified NKH l+T3 + cells mediate cytotoxicity at relatively low E/T ratios (Fig. 
3A).  For  comparison,  there  was  some ~hat  higher activity in  the  NKHI+T3 - 
population, but no cytotoxicity was mediated by NKH l-T3 + cells. Similar results 
were  seen  in  four  of five different experiments,  but in  one experiment,  both 
NKHI+T3 + and NKH l+T3 -  populations exhibited equivalent levels of cytotox- 
icity. Also shown  in  Fig.  3A,  addition  of monoclonal anti-T3  can  completely 
abrogate the  NK activity of NKHI+T3 + cells.  In control experiments, anti-T3 
did not abrogate NK activity on NKH 1  +T3- cells and anti-NKH 1A did not inhibit 
cytotoxicity of either NKH 1  +T3 + or NKH 1  +T3- cells (data not shown). 
The effect of anti-T3  was also evaluated with NKHI+T3 + lymphocytes that 
had been cultured in vitro for 14 d. After culture, cells were re-sorted to ensure 
the purity of the effector cell population before assessment of cytotoxicity. As 
shown in Fig. 3 B, cultured NKH 1  +T3 + cells display a high degree of cytotoxicity 
against K562 targets. Addition of anti-NKH 1A does not inhibit cytolytic activity, 
but incubation with anti-T3 results in marked inhibition. Addition of either anti- 
T8  or anti-Ia mAbs has no effect on cytotoxicity of NKHI+T3 + cells (data not 
shown). 
Discussion 
After purification  of NKHI+T3 + cells,  we  showed  that  this  subset  displays 
spontaneous cytotoxicity as well as the characteristic  LGL morphology of NK- 
active cells. Comparing NKH1 +T3- and NKH 1  +T3 ÷ cells, both exhibit typical 
LGL morphology, but  in  some individuals, azurophilic  granules appear  more 
pronounced in the NKH l+T3 -  subset. This finding is consistent with results of SCHMIDT  ET  AL.  BRIEF  DEFINITIVE  REPORT  355 
functional assays, since NKHI+T3  -  cells display somewhat higher spontaneous 
cytotoxicity  than NKH 1  +T3 + cells. Nevertheless, both NKH 1  + fractions maintain 
high levels of NK activity compared with NKH1-T3 + cells,  which do not kill 
K562 targets. 
Since  T3  antigen  is  noncovalently associated  with  the  T  cell  receptor  for 
antigen (Ti), and is required for surface membrane expression of Ti-like struc- 
tures,  we  used anti-T3  antibody to  determine whether  NKHI+T3  + NK  cells 
were functionally related to T  cells.  As described previously for T3 + NK clones 
(6),  cytotoxicity of NKHI+T3  ÷  NK  ceils  could  be  blocked  by anti-T3.  Since 
incubation with anti-T3 results in comodulation of both T3 and Ti these results 
suggest that T3+NKH1 + cells  use a  T  cell  receptor-like structure to interact 
with specific targets. These results were confirmed when purified NKHI+T3  ÷ 
cells were cultured for 14 d, re-sorted, and then tested for NK activity. Cultured 
ceils maintained a high degree of cytolytic activity, which could be inhibited by 
anti-T3 but not by antibodies specific for NKH 1, T8, or Ia antigens. 
Although the majority of NK cells do not express T3, there have been previous 
indications that a subset of NK cells is functionally related to T  lymphocytes. In 
particular, recent studies of both human and murine NK clones have shown that 
some clones have a  mature T  cell phenotype, express clonotypic receptors for 
antigen, and have functional rearrangement and expression of T  cell receptor 
genes (6,  9,  10).  Although the analysis of cultured T3 + NK clones may reflect 
some degree of in vitro selection of cells with a complete T  cell phenotype, we 
have recently shown that clonotypic antigens of NK clones can also be found in 
low frequency in uncultured peripheral blood (11).  Lymphokine activated killer 
(LAK) cells,  may also represent an expansion of this population of cells.  LAK 
cells have been shown to express a T  cell phenotype after in vitro culture (12), 
and the majority also express NKH 1. 
Although some NK clones appear to have functional characteristics of mature 
T  cells, the majority of NK clones do not express T3 antigen or T  cell receptors 
for antigen, and do not have functional rearrangements of T  cell receptor genes 
(9). Similarly the majority of NK cells in peripheral blood do not express T3 and 
do not appear  to use T  cell-like receptors  for target antigen (5).  NKHI+T3  + 
NK cells therefore appear to be a unique and functionally distinct population of 
NK cells,  which can be distinguished from cytotoxic T  cells  as  they can kill  a 
variety of targets in an MHC-independent fashion. However, despite their broad 
reactivity, the present studies also suggest that this subset of NK cells can mediate 
their functional activity through a T  cell receptor-like structure. 
Summary 
Normal human PBMC were analyzed for the presence of ceils expressing both 
T3  and  NKH1  antigens,  using  direct  two-color  immunofluorescence. In  six 
individuals, NKH l+T3 + cells were found to represent 2.5% of PBMC and 24% 
of the total number of NKH1 + cells.  Purified NKHI+T3  + ceils were shown to 
have the typical morphology of large granular lymphocytes (LGL). NKHI+T3  + 
cells also exhibited spontaneous cytotoxicity against K562  target cells  and this 
lytic activity could be inhibited by anti-T3 mAb. Similar results were obtained 
with  NKHI+T3  + cells  cultured  in  vitro  in  lymphocyte-conditioned medium. 356  SCHMIDT  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Taken together, these results indicate that NKH l+T3 + cells represent a  unique 
population of NK-active cells  in  normal peripheral  blood.  Although these cells 
exhibit  LGL morphology and NK activity, this appears to be mediated through 
a  functional T  cell-like receptor for target antigen. 
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